open access

Vol 69, No 3-4 (2019)
Review articles
Published online: 2019-10-31
Get Citation

Management of metastases in regional lymph nodes in melanoma patients in 2019

Wojciech M. Wysocki, Piotr Rutkowski
DOI: 10.5603/NJO.2019.0021
·
Nowotwory. Journal of Oncology 2019;69(3-4):108-110.

open access

Vol 69, No 3-4 (2019)
Review articles
Published online: 2019-10-31

Abstract

For several years, the standard of management in case of melanoma metastases in regional lymph nodes was to remove an adequate node group. In 2016 and 2017, the results of two large, well-designed clinical trials with randomization and a control group were published, which changed the current management. The authors of DeCOG-STL study came to the conclusion that withdrawal from completion lymph node dissection in the case of a small melanoma metastasis in a sentinel lymph node (metastasis diameter ≤1 mm) is not associated with a worsening of the 3-years’ survival chance (both in terms of overall survival and survival time to the occurrence of distant metastases). The results of MSTL-II study were similar. Based on the results of both studies presented above, in 2018 the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) presented joint recommendations concerning, among others, current indications for completion lymph node dissection in SNB positive melanoma patients.

Abstract

For several years, the standard of management in case of melanoma metastases in regional lymph nodes was to remove an adequate node group. In 2016 and 2017, the results of two large, well-designed clinical trials with randomization and a control group were published, which changed the current management. The authors of DeCOG-STL study came to the conclusion that withdrawal from completion lymph node dissection in the case of a small melanoma metastasis in a sentinel lymph node (metastasis diameter ≤1 mm) is not associated with a worsening of the 3-years’ survival chance (both in terms of overall survival and survival time to the occurrence of distant metastases). The results of MSTL-II study were similar. Based on the results of both studies presented above, in 2018 the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) presented joint recommendations concerning, among others, current indications for completion lymph node dissection in SNB positive melanoma patients.

Get Citation

Keywords

melanoma; SNB; completion lymphadenectomy

About this article
Title

Management of metastases in regional lymph nodes in melanoma patients in 2019

Journal

Nowotwory. Journal of Oncology

Issue

Vol 69, No 3-4 (2019)

Pages

108-110

Published online

2019-10-31

DOI

10.5603/NJO.2019.0021

Bibliographic record

Nowotwory. Journal of Oncology 2019;69(3-4):108-110.

Keywords

melanoma
SNB
completion lymphadenectomy

Authors

Wojciech M. Wysocki
Piotr Rutkowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl